Ontario Clinical Oncology Group (ocog)

This study is testing whether a different dosing schedule for the drug elranatamab can make treatment safer and allow patients with advanced multiple myeloma to receive it as outpatients. The trial involves 40 patients whose cancer has returned or stopped responding to at least t…

This study is for men whose prostate cancer has returned and spread to a few sites after initial radiation treatment. It aims to see if adding a 12-month course of hormone-blocking therapy to targeted radiation treatments works better than targeted radiation alone at keeping the …

This study is testing whether women with early-stage breast cancer who have no cancer left after chemotherapy can safely skip radiation therapy after breast-conserving surgery. It will follow 352 women aged 50+ who had a complete response to chemo to see if their cancer returns w…

This study is testing whether a specific molecular test, combined with certain patient and tumor features, can identify women with a low-risk form of early breast cell changes (DCIS) who can safely avoid radiation therapy after breast-conserving surgery. It will follow about 526 …

This study compares two radiation approaches for women with early-stage breast cancer. It tests whether targeting just the tumor area for one week works as well as treating the whole breast at preventing cancer from returning, while also aiming for better cosmetic results. The tr…